Vinod Ravi

The University of Texas MD Anderson Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102)

(2023)10.1158/1078-0432.c.6532743

Top 100%

0DataRank

Top 100%0 citations

Roberto Carmagnani Pestana, Jason Roszik, David S. Hong, Aung Naing, Siqing Fu +18 more

Papers

Driven by 13 papers — median percentile 0. Top paper: “Phase 2 study of pembrolizumab in patients with advanced rare cancers”.

Phase 2 study of pembrolizumab in patients with advanced rare cancers

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000347

N/A

4.0DataRank · unranked

131 citations

Funda Meric‐Bernstam, Bettzy Stephen, Daniel D. Karp, Joud Hajjar, Jordi Rodon Ahnert +35 more

A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma

Nature Cancer(2024)10.1038/s43018-024-00726-z

N/A

0.612DataRank · unranked

58 citations

Elise F. Nassif, Emily Z. Keung, Wei‐Lien Wang, Alexander J. Lazar, Heather Lin +54 more

Combined VEGFR and MAPK pathway inhibition in angiosarcoma

Scientific Reports(2021)10.1038/s41598-021-88703-9

N/A

0.533DataRank · unranked

34 citations

Yasmin A. Lyons, Jean Siedel, Robert Dood, Archana S. Nagaraja, Monika Haemmerle +8 more

Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102)

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2509

N/A

0DataRank · unranked

9 citations

Roberto Carmagnani Pestana, Jason Roszik, David S. Hong, Aung Naing, Siqing Fu +18 more

Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101)

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3629

N/A

0DataRank · unranked

21 citations

Justin T. Moyers, Jason Roszik, Shiraj Sen, David S. Hong, Aung Naing +29 more

Outcomes after definitive treatment for cutaneous angiosarcomas of the face and scalp: Reevaluating the role of surgery and radiation therapy

Head & Neck(2023)10.1002/hed.27418

N/A

0DataRank · unranked

6 citations

Ahsan Farooqi, Cort Wernz, Aparna Subramaniam, Vinod Ravi, Ryan P. Goepfert +5 more

Data from Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102)

(2023)10.1158/1078-0432.c.6532743

Top 100%

0DataRank

Top 100%0 citations

Roberto Carmagnani Pestana, Jason Roszik, David S. Hong, Aung Naing, Siqing Fu +18 more

Data from Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102)

(2023)10.1158/1078-0432.c.6532743.v1

Top 100%

0DataRank

Top 100%0 citations

Roberto Carmagnani Pestana, Jason Roszik, David S. Hong, Aung Naing, Siqing Fu +18 more

Incidence and Presenting Characteristics of Angiosarcoma in the US, 2001-2020

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.6235

N/A

0DataRank · unranked

43 citations

Vinod Ravi, Stephanie K. Schaub, E.Y. Kim, Jeremy Sharib, Harveshp Mogal +11 more

Dedifferentiated liposarcomas treated with immune checkpoint blockade: the MD Anderson experience

Frontiers in Immunology(2025)10.3389/fimmu.2025.1567736

N/A

0DataRank · unranked

4 citations

Cheuk Hong Leung, Marianne Zoghbi, Rossana Lazcano, Davis R. Ingram, Khalida Wani +21 more

Hyalinization-based pathologic response and immune infiltration following neoadjuvant radiotherapy with or without immune-checkpoint blockade in localized undifferentiated pleomorphic sarcoma

ESMO Open(2025)10.1016/j.esmoop.2025.105493

N/A

0DataRank · unranked

1 citations

Mohamad El Zoghbi, Rossana Lazcano, Brandon Cope, Andrew J. Bishop, Ahsan Farooqi +24 more

Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) study

npj Precision Oncology(2021)10.1038/s41698-021-00159-2

N/A

0DataRank · unranked

27 citations

David S. Hong, Siqing Fu, Daniel D. Karp, Sarina A. Piha‐Paul, Merrill S. Kies +16 more

Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma

Nature Communications(2022)10.1038/s41467-022-30496-0

N/A

0DataRank · unranked

194 citations

Narasimhan P. Agaram, Sally E. Trabucco, Victoria Robinson, Richard Ferraro, Sherri Z. Millis +38 more

Vinod Ravi

Indexed papers

Top data-sharing exemplar

Papers